Opiant Pharmaceuticals Inc Receivables Turnover Ratio (OPNT), from the third quarter 2022 to the third quarter 2021 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Opiant Pharmaceuticals Inc   (NASDAQ: OPNT)
 

Opiant Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2022 to the third quarter 2021

Quarterly Results, Trends, Rankings, Statistics


Opiant Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 4.1, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Opiant Pharmaceuticals Inc 's Accounts Receivable average collection period in the Sep 30 2022 quarter, has increased to 89 days, from 88 days, in the Jun 30 2022 quarter.

If we take a look into Healthcare sector 498 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2022 from 2879 to 3202.

What is Receivable Turnover Ratio?
What is Opiant Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OPNT Receivables Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Receivable Change -99.73 % -59.15 % -20.6 % 49.56 % 79.09 %
Y / Y Revenue Change -98.94 % -65.41 % -30.01 % 39.06 % 79.43 %
Receivable Turnover Ratio (TTM) 4.1 4.14 4.27 4.34 4.43
OPNT's Total Ranking # 3202 # 2879 # 1104 # 2406 # 3188
Accounts Receivable average collection period days 89 88 85 84 82
Seq. Receivable Change -98.97 % -10.8 % -66.58 % -13.6 % 58.62 %
Seq. Revenue Change -95.54 % -12.88 % -67.61 % -15.54 % 45.12 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 175
Healthcare Sector # 499
Overall Market # 3202

Receivable Turnover Ratio Statistics
High Average Low
30.83 6.79 1.54
(Jan 31 2017)   (Jul 31 2016)





OPNT Company Profile • Back to OPNT Efficiency Comparisons • Compare OPNT Receivables Turnover Ratio to its Competitors

Financial Statements
Opiant Pharmaceuticals Inc 's Accounts Receivable $ 0 Millions Visit OPNT's Balance sheet
Opiant Pharmaceuticals Inc 's Sales TTM $ 22 Millions Visit OPNT's Income Statement
Sources of OPNT's Revenues Visit OPNT's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OPNT's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OPNT's Growth Rates OPNT's Roa OPNT's Inventory Turnover Ratio OPNT's Dividend Comparisons
OPNT's Profitability Ratios OPNT's Roi OPNT's Asset Turnover Ratio OPNT's Dividend Growth
OPNT's Valuation Ratios OPNT's Roe OPNT's Financial Strength Ratios OPNT's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2022 Receivable at quarter ending Sep 30 2022
P3 Health Partners Inc   1,376.98 $ 1,282.322  Millions$ 0.931  Millions
Xoma Royalty Corporation  635.06 $ 40.485  Millions$ 0.064  Millions
Warby Parker Inc   610.14 $ 584.511  Millions$ 0.958  Millions
Marpai Inc  304.61 $ 22.609  Millions$ 0.074  Millions
Iqvia Holdings Inc   298.06 $ 14,307.000  Millions$ 48.000  Millions
Sigilon Therapeutics Inc   294.37 $ 12.290  Millions$ 0.042  Millions
Chimerix Inc   282.53 $ 33.056  Millions$ 0.117  Millions
Denali Therapeutics Inc   279.71 $ 110.694  Millions$ 0.396  Millions
Sunshine Biopharma Inc   250.30 $ 0.491  Millions$ 0.002  Millions
Bausch Health Companies Inc   227.33 $ 8,127.000  Millions$ 35.750  Millions
Waters Corporation  221.05 $ 2,949.895  Millions$ 13.345  Millions
Nexalin Technology Inc   210.71 $ 0.545  Millions$ 0.003  Millions
China Pharma Holdings Inc  191.12 $ 8.072  Millions$ 0.042  Millions
Clearday Inc   171.69 $ 12.391  Millions$ 0.072  Millions
4d Molecular Therapeutics Inc   167.91 $ 1.973  Millions$ 0.012  Millions
Arcus Biosciences Inc   149.36 $ 432.844  Millions$ 2.898  Millions
Lipocine Inc   136.01 $ 16.611  Millions$ 0.122  Millions
Streamex Corp   127.20 $ 0.159  Millions$ 0.001  Millions
Oragenics Inc   125.09 $ 0.219  Millions$ 0.002  Millions
Skinvisible Inc   119.54 $ 0.452  Millions$ 0.004  Millions
Atara Biotherapeutics Inc   111.65 $ 70.900  Millions$ 0.635  Millions

Date modified: 2026-09-08T15:10:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.